NASDAQ · ORKT

Orangekloud Technology Inc.

$1.05 -$0.02 (-1.87%) 1D Market open

Key Metrics

$6.25M
Market cap
P/E · TTM
Revenue · TTM
Net income
EPS · TTM
Dividend yield
Free cash flow −$3.84M
Beta · 1Y 0.92
EBITDA · TTM
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Apr 30
    From its Feb 2 high, the share price fell 38%.

    Peak close $1.45 on Feb 2; trough close $0.90 on Apr 30. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -38%
  • Feb 3
    The stock moved -28.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 3
  • Jan 30
    The stock moved +55.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jan 30

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$6.25M
Enterprise value$1.09M
Shares outstanding5.8M
52-wk range$0.62 – $3.48
Avg volume · 20D354.2K
Net cash $5.16M
Book value / share$1.13
ExchangeNASDAQ
About Orangekloud Technology Inc.
IPO dateJul 25, 2024
Employees64

Orangekloud Technology Inc is a company that operates through its subsidiaries to provide IT consultancy services and distribution of related products and services. The Company also offers ERPs predominantly in Singapore.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC — · —

Financial Health

Current ratio2.43
Quick ratio
Debt / equity0.03
Debt / EBITDA
Net cash $5.16M
Working capital$2.25M

Cash Flow · TTM

Operating CF −$3.55M
Capex −$292.07K
Free cash flow −$3.84M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2025-12-31 · computed by TickerWolf from SEC filings